LOCALLY ADVANCED TRIAL OF TRI-WEEKLY METRONOMIC ORAL VINORELBINE AND CISPLATIN AS INDUCTION THERAPY AND SUBSEQUENT CONCOMITANCE WITH RADIATION THERAPY IN PATIENTS WITH UNRESECTABLE NON SMALL CELL LUNG CANCER (NSCLC):